HAE
Price
$64.01
Change
+$0.99 (+1.57%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
4.33B
40 days until earnings call
HOLX
Price
$60.57
Change
-$0.81 (-1.32%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
17.87B
27 days until earnings call
Ad is loading...

HAE vs HOLX

Header iconHAE vs HOLX Comparison
Open Charts HAE vs HOLXBanner chart's image
Haemonetics
Price$64.01
Change+$0.99 (+1.57%)
Volume$4.75K
Capitalization4.33B
Hologic
Price$60.57
Change-$0.81 (-1.32%)
Volume$30.18K
Capitalization17.87B
HAE vs HOLX Comparison Chart
Loading...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HAE vs. HOLX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and HOLX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (HAE: $63.02 vs. HOLX: $61.38)
Brand notoriety: HAE and HOLX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 58% vs. HOLX: 64%
Market capitalization -- HAE: $4.33B vs. HOLX: $17.87B
HAE [@Medical Specialties] is valued at $4.33B. HOLX’s [@Medical Specialties] market capitalization is $17.87B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileHOLX’s FA Score has 0 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • HOLX’s FA Score: 0 green, 5 red.
According to our system of comparison, HOLX is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 3 TA indicator(s) are bullish while HOLX’s TA Score has 5 bullish TA indicator(s).

  • HAE’s TA Score: 3 bullish, 4 bearish.
  • HOLX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HOLX is a better buy in the short-term than HAE.

Price Growth

HAE (@Medical Specialties) experienced а -0.52% price change this week, while HOLX (@Medical Specialties) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +3.01%.

Reported Earning Dates

HAE is expected to report earnings on May 13, 2025.

HOLX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOLX($17.9B) has a higher market cap than HAE($4.34B). HOLX (36.08) and HAE (34.47) have similar P/E ratio . HOLX YTD gains are higher at: -15.994 vs. HAE (-17.982). HOLX has higher annual earnings (EBITDA): 1.06B vs. HAE (264M). HOLX has more cash in the bank: 1.93B vs. HAE (194M). HAE has less debt than HOLX: HAE (871M) vs HOLX (2.58B). HOLX has higher revenues than HAE: HOLX (3.97B) vs HAE (1.27B).
HAEHOLXHAE / HOLX
Capitalization4.34B17.9B24%
EBITDA264M1.06B25%
Gain YTD-17.982-15.994112%
P/E Ratio34.4736.0896%
Revenue1.27B3.97B32%
Total Cash194M1.93B10%
Total Debt871M2.58B34%
FUNDAMENTALS RATINGS
HAE vs HOLX: Fundamental Ratings
HAE
HOLX
OUTLOOK RATING
1..100
6819
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10054
SMR RATING
1..100
5754
PRICE GROWTH RATING
1..100
7863
P/E GROWTH RATING
1..100
8092
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (70) in the Medical Specialties industry is in the same range as HOLX (70). This means that HAE’s stock grew similarly to HOLX’s over the last 12 months.

HOLX's Profit vs Risk Rating (54) in the Medical Specialties industry is somewhat better than the same rating for HAE (100). This means that HOLX’s stock grew somewhat faster than HAE’s over the last 12 months.

HOLX's SMR Rating (54) in the Medical Specialties industry is in the same range as HAE (57). This means that HOLX’s stock grew similarly to HAE’s over the last 12 months.

HOLX's Price Growth Rating (63) in the Medical Specialties industry is in the same range as HAE (78). This means that HOLX’s stock grew similarly to HAE’s over the last 12 months.

HAE's P/E Growth Rating (80) in the Medical Specialties industry is in the same range as HOLX (92). This means that HAE’s stock grew similarly to HOLX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAEHOLX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
53%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 27 days ago
67%
Bullish Trend 7 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
64%
Bearish Trend 14 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
47%
View a ticker or compare two or three
Ad is loading...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FRI27.640.14
+0.51%
First Trust S&P REIT ETF
XCLR26.400.11
+0.43%
Global X S&P 500® Collar 95-110 ETF
FUTY51.300.20
+0.39%
Fidelity MSCI Utilities ETF
AAA24.970.03
+0.12%
Alternative AccessFirstPriorityCLO BdETF
IBMQ25.26-0.01
-0.04%
iShares iBonds Dec 2028 Term Muni Bd ETF

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with GH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+1.62%
GH - HAE
34%
Loosely correlated
+2.40%
OM - HAE
32%
Poorly correlated
+11.37%
HOLX - HAE
32%
Poorly correlated
-1.34%
ATR - HAE
31%
Poorly correlated
+0.96%
NEOG - HAE
31%
Poorly correlated
+2.38%
More

HOLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOLX has been loosely correlated with BDX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HOLX jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOLX
1D Price
Change %
HOLX100%
-1.34%
BDX - HOLX
52%
Loosely correlated
+0.17%
ZBH - HOLX
46%
Loosely correlated
+0.12%
ABT - HOLX
45%
Loosely correlated
+0.18%
DGX - HOLX
40%
Loosely correlated
-0.78%
RVTY - HOLX
36%
Loosely correlated
+2.31%
More